CD163 and neoplasm: Given LGALS9 upregulation in immune-hot tumors, we assessed tumor-associated macrophages via CD68 (pan-macrophage marker) and CD163 (M2 macrophage marker) IHC to evaluate their contribution to an immunosuppressive microenvironment.